Sign in
Taking people in United StatesNo phase

Setting magnetic stimulation dose for depression after spinal cord injury

Tests new rTMS dosing for depression after spinal cord injury.

Key facts

Who runs it
VA Office of Research and Development
Where
Charleston, United StatesSee the site
Trial code
Registry title
Dosing rTMS for Depression Post-SCI
Status
Recruiting
People taking part
24 people, planned
Started
31 Mar 2025
Expected to end
29 Oct 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • repetitive transcranial magnetic stimulation--Active
  • repetitive transcranial magnetic stimulation--Sham
Record updated
14 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with major depression after a spinal cord injury. It tests a new way to set the dose of rTMS, a magnetic brain stimulation treatment.

Age
18 to 60 years
Sex
All sexes
Disease stage
Spinal cord injury in the neck (cervical) or upper back (thoracic) at least 6 months ago, graded AIS A, B, C, or D. Major depressive disorder confirmed by a structured interview, with a Hamilton Depression Rating Scale-17 score > 18.
Earlier treatment
People must not be taking antidepressants, or must have had no change in psychiatric medicine doses for at least 4 weeks (6 weeks if the medicine was newly started).

Main reasons for not taking part

  • Other nervous system diseases, dementia, or memory and thinking problems (Montreal Cognitive Assessment <17)
  • History of psychosis, bipolar disorder, or another main psychiatric disorder
  • Metal or electronic implants such as metal in the head, cochlear implant, or pacemaker
  • History of seizures, seizure medicines, or medicines that raise seizure risk
  • Pregnancy, serious suicide risk or a suicide attempt in the past two years, or life expectancy <1 year

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • cervical or thoracic spinal cord injury at least 6 months prior with AIS A, B, C, or D
  • 18 - 60 years of age
  • major depressive disorder, as identified by Structured Clinical Interview for DSM-V
  • Hamilton Depression Rating Scale-17 score > 18
  • not taking antidepressant medications or no change in doses of psychotropic medication(s) for at least 4 weeks before the study (6 weeks if newly initiated medication)

Who cannot take part

  • concomitant neurologic diseases/disorders or dementia
  • electronic or metallic implants (i.e., metal in the head, cochlear implant, or pacemaker
  • Hamilton Depression Rating Scale-17 question #3 regarding suicide: >2 or suicide attempt within the previous two years
  • cognitive impairment (Montreal Cognitive Assessment <17)
  • history of psychosis or other Axis I disorder that is primary
  • positive screen for bipolar disorder through the Mini-International Neuropsychiatric Interview
  • history of claustrophobia
  • history of seizures or currently prescribed anti-seizure medications
  • taking medication that increases the risk of seizures
  • life expectancy <1 year
  • pregnancy as identified through a positive urine pregnancy test
  • inability to (University of California, San Diego Brief Assessment of Capacity to Consent) or declined to give informed consent

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

This trial is currently available in United States.

  • Ralph H. Johnson VA Medical Center, Charleston, SCCharleston, United StatesContact: Catherine J VanDerwerker, PhD DPT PTTaking people

About the trial

What the trial wants to find out

Depression is a leading cause of disability worldwide and is more commonly seen in individual's post-spinal cord injury (SCI) than in the general population. Depression post-SCI impacts an individuals' quality of life and recovery. It has been reported that among Veterans with an SCI, those without depression live longer than those with depression. Thus, depression must be treated appropriately. Repetitive transcranial magnetic stimulation (rTMS) is an FDA-approved treatment for depression, but dosing is based on a motor response or movement in the thumb. Over half of individuals with SCI have some degree of arm or hand impairment, so these individuals might not be eligible for rTMS, or they may receive the wrong dose. This study proposes clinical trial in individuals with depression post-SCI to assess the anti-depressant effect of a novel technique to dose rTMS that does not require a motor response in the thumb. By gaining a better understanding of the application of rTMS for depression post-SCI, the investigators aim to advance the rehabilitative care of Veterans.

The 2 groups in the trial

  • Active rTMSTreatment being tested

    Active repetitive transcranial magnetic stimulation (rTMS) that will be administered 5 days/week for 6 weeks. Intensity will be individualized based on reverse-calculation electric-field modeling.

    Treatment: repetitive transcranial magnetic stimulation--Active

  • Sham rTMSSham treatment, for comparison

    Sham repetitive transcranial magnetic stimulation (rTMS) that will be administered 5 days/week for 6 weeks. Intensity will be individualized based on reverse-calculation electric-field modeling, but a sham treatment coil will be used; thus, no active treatment will be administered.

    Treatment: repetitive transcranial magnetic stimulation--Sham

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating a Novel Method to Determine the rTMS Dose Needed for Treating Depression After Spinal Cord Injury
Plain-language title
Setting magnetic stimulation dose for depression after spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT05553353, who can take part
Record updated
14 January 2026